F.J. Carrilho

814 total citations
21 papers, 521 citations indexed

About

F.J. Carrilho is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, F.J. Carrilho has authored 21 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 9 papers in Hepatology and 7 papers in Surgery. Recurrent topics in F.J. Carrilho's work include Liver Disease Diagnosis and Treatment (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Liver Disease and Transplantation (3 papers). F.J. Carrilho is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Liver Disease and Transplantation (3 papers). F.J. Carrilho collaborates with scholars based in Brazil, United States and Spain. F.J. Carrilho's co-authors include Antoni Mas, Vicente Arroyo, Joan Rodés, Jaime Bosch, Amadeo Betriu, Francisca Rivera, José Tadeu Stefano, Daniel Ferraz de Campos Mazo, Cláudia P. Oliveira and Luca Miele and has published in prestigious journals such as Annals of Internal Medicine, Gastroenterology and Journal of Hepatology.

In The Last Decade

F.J. Carrilho

19 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F.J. Carrilho Brazil 7 288 276 163 118 87 21 521
Takumi Akiyama Japan 12 249 0.9× 272 1.0× 163 1.0× 126 1.1× 39 0.4× 25 534
Assaf Issachar Israel 13 273 0.9× 298 1.1× 133 0.8× 59 0.5× 36 0.4× 27 620
Ethem Tankurt Türkiye 13 171 0.6× 230 0.8× 127 0.8× 67 0.6× 134 1.5× 34 499
Murat Kıyıcı Türkiye 11 182 0.6× 305 1.1× 100 0.6× 35 0.3× 34 0.4× 40 469
John H. Helzberg United States 13 205 0.7× 221 0.8× 200 1.2× 185 1.6× 63 0.7× 32 579
Signe Wiese Denmark 13 464 1.6× 406 1.5× 182 1.1× 43 0.4× 51 0.6× 32 627
Amedeo Ligabue Italy 10 309 1.1× 246 0.9× 134 0.8× 48 0.4× 28 0.3× 12 490
Paolo Buonamico Italy 12 331 1.1× 310 1.1× 217 1.3× 118 1.0× 36 0.4× 21 630
Martha H. Ramos Mexico 12 190 0.7× 421 1.5× 158 1.0× 110 0.9× 59 0.7× 17 647
Antony M. Wheatley New Zealand 12 143 0.5× 216 0.8× 402 2.5× 66 0.6× 73 0.8× 17 635

Countries citing papers authored by F.J. Carrilho

Since Specialization
Citations

This map shows the geographic impact of F.J. Carrilho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F.J. Carrilho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F.J. Carrilho more than expected).

Fields of papers citing papers by F.J. Carrilho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F.J. Carrilho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F.J. Carrilho. The network helps show where F.J. Carrilho may publish in the future.

Co-authorship network of co-authors of F.J. Carrilho

This figure shows the co-authorship network connecting the top 25 collaborators of F.J. Carrilho. A scholar is included among the top collaborators of F.J. Carrilho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F.J. Carrilho. F.J. Carrilho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Balderramo, Domingo, Enrique Carrera, Fernando Javier Barreyro, et al.. (2018). PIB: A Score to Select Sorafenib Treatment Candidates for Hepatocellular Carcinoma in Resource-Limited Settings. Hepatitis Monthly. In Press(In Press). 2 indexed citations
2.
Stefano, José Tadeu, Luca Miele, Francesca Romana Ponziani, et al.. (2017). Gut microbiome composition in lean patients with NASH is associated with liver damage independent of caloric intake: A prospective pilot study. Nutrition Metabolism and Cardiovascular Diseases. 28(4). 369–384. 109 indexed citations
3.
Terrabuio, Débora Raquel Benedita, et al.. (2016). Allopurinol is Safe and Effective to Achieve Biochemical and Histological Remission in Patients with Autoimmune Hepatitis with Incomplete Therapeutic Response. Journal of Hepatology. 64(2). S435–S435. 1 indexed citations
4.
Stefano, José Tadeu, Luiz Augusto Perandini, Ana Lúcia de Sá‐Pinto, et al.. (2015). P1028 : Impaired aerobic capacity and cardiac autonomic control in sedentary postmenopausal women with Nonalcoholic Fatty Liver Disease (NAFLD). Journal of Hepatology. 62. S733–S733. 3 indexed citations
5.
Strasser, Simone I., Alan Wigg, Rebecca Jones, et al.. (2013). Liver resection and transplantation offer similar 5-year survival for Child-Pugh-Turcotte A HCC-patients with a single nodule up to 5 cm: A multicenter, exploratory analysis. European Journal of Surgical Oncology. 39(4). 386–395. 26 indexed citations
6.
Alves, Venâncio Avancini Ferreira, et al.. (2013). 1353 EFFECTS OF omega-3 POLYUNSATURATED FATTY ACIDS (PUFA) FROM FISH AND FLAXSEED OILS ON NONALCOHOLIC STEATOHEPATITIS (NASH). Journal of Hepatology. 58. S544–S544. 2 indexed citations
7.
Poynard, Thierry, Jordi Bruix, Eugene R. Schiff, et al.. (2012). Improved inflammatory activity with peginterferon alfa-2b maintenance therapy in non-cirrhotic prior non-responders: A randomized study. Journal of Hepatology. 58(3). 452–459. 6 indexed citations
8.
Klautau, Giselle Burlamaqui, et al.. (2012). 141 VITAMIN D AND CHOLESTEROL SERUM LEVELS ARE INVERSELY ASSOCIATED IN HCV, HIV AND HIV/HCV COINFECTED PATIENTS. Journal of Hepatology. 56. S62–S62. 1 indexed citations
9.
Oliveira, Cristina, José Tadeu Stefano, Hermes Vieira Barbeiro, et al.. (2012). 173 CONVENTIONAL AND NOVEL CARDIOVASCULAR RISK FACTORS IN LIVER TRANSPLANT RECIPIENTS (LTR). Journal of Hepatology. 56. S75–S76. 1 indexed citations
10.
11.
Zhu, Andrew X., Olivier Rosmorduc, Paul J. Ross, et al.. (2012). Search: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Sorafenib Plus Erlotinib in Patients with Hepatocellular Carcinoma (HCC). Annals of Oncology. 23. ixe11–ixe11. 40 indexed citations
12.
Kishi, Humberto S., et al.. (2011). Narrow-band imaging and chromoendoscopy for the detecion of colonic dysplasia in inflammatory bowel disease: a prospective and randomized study. Inflammatory Bowel Diseases. 17. S14–S15. 10 indexed citations
13.
Nita, Marcelo Eidi, et al.. (2010). Clinical trials profile: Professionals and sites. Contemporary Clinical Trials. 31(5). 438–442. 5 indexed citations
14.
Mazo, Daniel Ferraz de Campos, et al.. (2010). W1567: Elastic Ligature: Promising Method in the Treatment of Hemorrhagic Gastric Angiodysplasia. Gastrointestinal Endoscopy. 71(5). AB360–AB360.
15.
16.
Artifon, Everson L.A., Paulo Sakai, Shinichi Ishioka, et al.. (2008). Endoscopic Sphincterotomy Before Deployment of Covered Metal Stent is Associated With Greater Complication Rate. Journal of Clinical Gastroenterology. 42(7). 815–819. 47 indexed citations
17.
Medeiros, Denise Machado, Ana Cristina Mendes de Oliveira, Edson Abdala, et al.. (2004). Early mortality in liver transplantation: bilirubin as predictor of outcome. Transplantation Proceedings. 36(4). 931–932. 5 indexed citations
18.
S, Ono, et al.. (1995). Long term follow-up and patterns of response of ALT in patients with chronic hepatitis NANB/C treated with recombinant interferon-alpha. Revista do Instituto de Medicina Tropical de São Paulo. 37(3). 239–243. 2 indexed citations
19.
Bosch, Jaime, Vicente Arroyo, Amadeo Betriu, et al.. (1980). Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis. Gastroenterology. 78(1). 92–99. 212 indexed citations
20.
Carrilho, F.J., et al.. (1977). Renal Failure Associated with Demeclocycline in Cirrhosis. Annals of Internal Medicine. 87(2). 195–197. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takumi Akiyama Breakdown of academic impact, for papers by Assaf Issachar Breakdown of academic impact, for papers by Ethem Tankurt Breakdown of academic impact, for papers by Murat Kıyıcı Breakdown of academic impact, for papers by John H. Helzberg Breakdown of academic impact, for papers by Signe Wiese Breakdown of academic impact, for papers by Amedeo Ligabue Breakdown of academic impact, for papers by Paolo Buonamico Breakdown of academic impact, for papers by Martha H. Ramos Breakdown of academic impact, for papers by Antony M. Wheatley
Rankless by CCL
2026